Medical specialty dealing with disorders of the nervous system
POPULARITY
Categories
1,185 episodes with Neurology
834 episodes with Neurology
300 episodes with Neurology
159 episodes with Neurology
169 episodes with Neurology
105 episodes with Neurology
96 episodes with Neurology
80 episodes with Neurology
167 episodes with Neurology
105 episodes with Neurology
91 episodes with Neurology
86 episodes with Neurology
90 episodes with Neurology
152 episodes with Neurology
54 episodes with Neurology
53 episodes with Neurology
73 episodes with Neurology
46 episodes with Neurology
75 episodes with Neurology
59 episodes with Neurology
48 episodes with Neurology
58 episodes with Neurology
47 episodes with Neurology
30 episodes with Neurology
52 episodes with Neurology
53 episodes with Neurology
51 episodes with Neurology
28 episodes with Neurology
55 episodes with Neurology
59 episodes with Neurology
44 episodes with Neurology
29 episodes with Neurology
23 episodes with Neurology
80 episodes with Neurology
20 episodes with Neurology
27 episodes with Neurology
42 episodes with Neurology
24 episodes with Neurology
53 episodes with Neurology
17 episodes with Neurology
30 episodes with Neurology
12 episodes with Neurology
24 episodes with Neurology
25 episodes with Neurology
30 episodes with Neurology
19 episodes with Neurology
22 episodes with Neurology
26 episodes with Neurology
22 episodes with Neurology
24 episodes with Neurology
19 episodes with Neurology
13 episodes with Neurology
22 episodes with Neurology
21 episodes with Neurology
Dr. Jason Crowell talks with Dr. YuHong Fu about the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. Read the related article in Nature. Disclosures can be found at Neurology.org.
Dr. Dan Ackerman and Dr. Isabel Hostettler discuss the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Show reference: Hostettler IC, Ponciano A, Wilson D, et al. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis. Neurology. 2025;105(5):e213984. doi:10.1212/WNL.0000000000213984
In this episode, we review the high-yield topic of Aneurysms from the Neurology section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
Neurologist, executive, and historian Dr. Jack McCallum joins the program to discuss the remarkable evolution of the human brain. His latest work examines how the brains of younger generations are fundamentally different from those of older generations.Driven by social media, technology, and shifting societal values, McCallum argues that our brains are actively adapting to meet the demands of modern life. Through compelling historical and contemporary examples, he invites listeners to see human development in a completely new light.Follow Dr McCallum on his website at https://JackMcCallumMD.com or on his Substack at https://changingbrain.substack.com/See exclusives and more at https://SarahWestall.Substack.com
In this episode, we review the high-yield topic of Meningitis from the Neurology section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
The signs and symptoms we feel when our brain is impaired can be anything from headaches to mental health struggles to really any body function not operating well. The brain is our body's control center. Dr. Ali Elahi has studied for years to find ways to improve brain function quickly and without pharmaceuticals. He shares several techniques he uses including transcranial magnetic stimulation.Transcranial magnetic stimulation (TMS) is a significant technological breakthrough that is quickly replacing use of medications for non-pharmacological treatment of numerous neurological conditions including depression, anxiety, chronic pain, Parkinson's, and stroke.Dr. Ali Elahi, the founder of NeuroSpa Brain Rejuvenation Centers, is board-certified by the American Board of Psychiatry and Neurology (ABPN) and practicing neurology for nearly 20 years. Subscribe to his YouTube Channel @neurospabrain and follow on Instagram @neurospabrain. Visit ConfidenceThroughHealth.com to find discounts to some of our favorite products.Follow me via All In Health and Wellness on Facebook or Instagram.Find my books on Amazon: No More Sugar Coating: Finding Your Happiness in a Crowded World and Confidence Through Health: Live the Healthy Lifestyle God DesignedProduction credit: Social Media Cowboys
Not every episode that looks like a seizure is one, and for pediatricians, distinguishing the difference can be challenging. Few moments in the clinic can feel as urgent, or as uncertain, as evaluating spells. In this episode, we unravel the mysteries of seizures and their mimics to prevent misdiagnosis and avoid unnecessary intervention. This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. Joining us is Shavonne Massey, MD. She is a neurologist at Children's Hospital of Philadelphia and an Assistant Professor of Neurology at the University of Pennsylvania School of Medicine. Some highlights from this episode include: Differentiators between seizures and mimics What pediatricians can do when a child is experiencing a seizure Key factors they can look for during an exam Most common seizure mimics that present in children depending on age For more information on Children's Colorado, visit: childrenscolorado.org.
What if the key to treating neurodegenerative diseases lies not in attacking symptoms, but in healing mitochondria? Dr. Matthew Phillips, a neurologist who coined the term "metabolic neurologist," shares groundbreaking insights from his decade-long journey implementing ketogenic diets and fasting protocols for Parkinson's, Alzheimer's, and glioblastoma patients.In this episode, Dr. Phillips reveals his clinical framework combining metabolic therapies with standard of care, his current glioblastoma trial utilizing 5-day fasting cycles with chemotherapy, and why he believes mitochondrial dysfunction is the root cause of neurodegeneration.Questions Answered in This Episode:What initially drew you to understanding brain metabolism and how did your journey begin?How do you implement metabolic therapies in practice and determine patient candidacy?What is the most clinically relevant mechanism of metabolic therapy?Does your trial evidence suggest metabolic interventions are adjunctive or disease-modifying treatments?Why aren't metabolic therapies more widely adopted for conditions where conventional options are limited?What power do patients have to prevent or address early cognitive decline through their own actions?Dr. Phillips challenges the medical dogma that has kept metabolic therapies on the sidelines, advocating for a merger of "germ theory" and "terrain theory" approaches that could revolutionize how we treat the most devastating neurological conditions.Sign-up to our Live Q&A Exploring Metabolic Neurology with Dr. Phillips here.Learn more about Dr. Phillips on his website.Special thanks to the sponsors of this episode:✅Genova Connect – Get 15% off any test kit with code METABOLICLINK here.✅ iRestore - Get a huge discount on the iRestore Illumina Face Mask when you use the code METABOLICLINK here.✅Piquelife.com - Get the Pu'er Bundle for 20% off here.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.
In this episode, we review the high-yield topic of Brown-Sequard Syndrome from the Neurology section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
Dr. Dan Ackerman talks with Dr. Isabel Hostettler about the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Gominak grew up and attended college in California, moved to Houston for medical school at Baylor College of Medicine, where she received an MD degree in 1983. Her Neurology residency was done at the Harvard affiliated, Massachusetts General Hospital in Boston. She practiced Neurology in the San Francisco Bay area from 1991-2004 then moved with her husband to Tyler, Texas. Starting in 2004 she began to dedicate more of her practice to the treatment of sleep and sleep disorders. In 2012 and 2016 she published two pivotal articles about the global struggle with worsening sleep, the possible causes and solutions, related to vitamin D deficiency and the intestinal microbiome. In 2016 she retired from her office practice to have more time to teach. She currently divides her time between RightSleep® coaching sessions for private individuals, teaching about sleep and sleep disorders on her channel, youtube.com/@DrStashaGominak and teaching other clinicians the RightSleep® method of sleep repair. In this episode, we chat about: The cause of your headaches you're not looking into What does fat bear week have to do with hormones Is vitamin D at the root of endometriosis and PCOS Thoughts and feelings about sunscreen How medicine has lost critical thinking ability Covid and vitamin D Why your doctor is saying no to vitamin D testing Learn more about working with me Shop my masterclasses (learn more in 60-90 minutes than years of dr appointments) Follow me on IG Follow Empowered Mind + Body on IG Learn more about working with Dr. Stasha Gominak Follow Dr. Stasha Gominak on IG
In this episode, we review the high-yield topic of Frontotemporal Dementia (Pick Disease) from the Neurology section.Follow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbullets
Psilocybin is a psychedelic chemical derived from mushrooms. It is under study for mood problems in people with ALS. Here we review its plausible mechanisms for slowing ALS progression. But there are no data from preclinical models, trials or case reports that currently support this benefit. And there can be serious risks to using this chemical.
The Smart 7 is an award winning daily podcast, in association with METRO that gives you everything you need to know in 7 minutes, at 7am, 7 days a week...With over 19 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and the Sunday 7 won a Gold Award as “Best Conversation Starter” in the International Signal Podcast Awards If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests:David Liu - Professor of the Natural Sciences at Harvard University, specialising in Molecular Biology and Organic ChemistrySteven Pinker - The Johnstone Family Professor of Psychology at Harvard University, Mark Zuckerberg = Founder and CEO of Facebook.Frances Balkwill = Professor of Cancer Biology at Queen Mary College Hospital Doctor Alexandra Solomon - Clinical psychologist, and Associate Professor at Northwestern University Dr Ed Robinson - Specialist in Cosmetic Aesthetics, and Associate member of the British College of Aesthetic Medicine Stephen Childs - Lab Technician and Analyst at Sunderland UniversityKerry Nicol - External Affairs Manager for the Chartered Trading Standards Institute Joe Morse = Associate Test Pilot for US Company Pivotal Ken Clarkin - CEO of Pivotal Dr Randy Bateman - Professor of Neurology at Washington University Dr Christos Pliatsikas -Associate Professor at the School of Psychology and Clinical Sciences at the University of Reading Paulina Arce - Veterinary expert, specialising in the Humboldt Penguin Guillermo Cubillos - Marine Biologist at Chile's National ZooContact us over @TheSmart7pod or visit www.thesmart7.com or find out more at www.metro.co.uk Presented by Ciara Revins, written by Liam Thompson, researched by Lucie Lewis and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.
This accredited continuing education program is supported by an educational grant from Sanofi. Credit for the program can be obtained by visiting https://checkrare.com/learning/p-consider-rare-suspecting-and-diagnosing-cidp/ . This program, led by Jeffrey Allen, MD, Professor of Neurology at the University of Minnesota provides an overview on the diagnostic delays that often occur in patients with CIDP as well as best practices to suspect and diagnose this rare condition more efficiently. This activity has been designed to meet the educational needs of physicians specializing in family medicine, pediatrics, and neurology. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the early symptoms of CIDP.List best practices which can be used to diagnose CIDP more efficiently.Faculty Jeffrey Allen, MDProfessor of NeurologyDepartment of NeurologyDivision of Neuromuscular MedicineUniversity of MinnesotaMinneapolis, MNDisclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Scott discloses Consultant/Educational talks: Annexon, Alexion, Amgen, CSL Behring, Takeda,BioCryst, Grifols, Argenx, Sanofi, Immunovant, ImmunoAbs, Octapharma, Alnylam, AstraZeneca, Dianthus, Johnson & Johnson, Laboratoire Français du Fractionnement et des Biotechnologies, Nuvig, Akcea Therapeutics, ImmunoPharma,Pfizer.Community Faculty/Patient (Christine Eleeson): No relevant financial relationships with any ineligible companies.Other Planners for this activity have no relevant financial relationships with any ineligible companies.This activity will review off-label or investigational information.The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation.There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre-and post-program assessments. Your certificate will be emailed to you within 30 days.PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
En este episodio, exploramos un fenómeno cada vez más inquietante en las consultas y unidades de neurología: el aumento del ictus en adultos jóvenes. A partir de la evidencia más reciente, analizamos cómo los factores de riesgo clásicos están dando paso a nuevos protagonistas del siglo XXI, entre ellos el estrés crónico. Revisamos el papel del ictus criptogénico, las causas vasculares menos conocidas y los mecanismos por los cuales la sobrecarga emocional, laboral o social puede alterar la fisiología cerebrovascular hasta precipitar un evento agudo. También abordamos la diferencia de impacto entre hombres y mujeres, los hallazgos de estudios internacionales como INTERSTROKE y ERICH, y cómo la gestión del estrés debería considerarse una estrategia real de prevención neurológica. Un episodio para reflexionar sobre la relación entre mente, sociedad y cerebro en una generación que vive —y enferma— bajo presión. Referencias del episodio: 1. Behymer, T. P., Sekar, P., Demel, S. L., Aziz, Y. N., Coleman, E. R., Williamson, B. J., Stanton, R. J., Sawyer, R. P., Turner, A. C., Vagal, V. S., Osborne, J., Gilkerson, L. A., Comeau, M. E., Flaherty, M. L., Langefeld, C. D., & Woo, D. (2025). Psychosocial Stress and Risk for Intracerebral Hemorrhage in the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) Study. Journal of the American Heart Association, 14(6), e024457. https://doi.org/10.1161/JAHA.121.024457 (https://pubmed.ncbi.nlm.nih.gov/40055853/). 2. Egido, J. A., Castillo, O., Roig, B., Sanz, I., Herrero, M. R., Garay, M. T., Garcia, A. M., Fuentes, M., & Fernandez, C. (2012). Is psycho-physical stress a risk factor for stroke? A case-control study. Journal of neurology, neurosurgery, and psychiatry, 83(11), 1104–1110. https://doi.org/10.1136/jnnp-2012-302420 (https://pubmed.ncbi.nlm.nih.gov/22930814/). 3. Gutiérrez-Zúñiga, R., Fuentes, B., & Díez-Tejedor, E. (2018). Ictus criptogénico. Un no diagnóstico. Medicina Clínica, 151 (3), 116-122. https://doi.org/10.1016/j.medcli.2018.01.024 (https://www.sciencedirect.com/science/article/abs/pii/S0025775318300770). 4. Khan, M., Wasay, M., O'Donnell, M. J., Iqbal, R., Langhorne, P., Rosengren, A., Damasceno, A., Oguz, A., Lanas, F., Pogosova, N., Alhussain, F., Oveisgharan, S., Czlonkowska, A., Ryglewicz, D., & Yusuf, S. (2023). Risk Factors for Stroke in the Young (18-45 Years): A Case-Control Analysis of INTERSTROKE Data from 32 Countries. Neuroepidemiology, 57(5), 275–283. https://doi.org/10.1159/000530675 (https://pubmed.ncbi.nlm.nih.gov/37231971/). 5. Kutal, S., Tulkki, L. J., Sarkanen, T., Redfors, P., Jood, K., Nordanstig, A., Yeşilot, N., Sezgin, M., Ylikotila, P., Zedde, M., Junttola, U., Fromm, A., Ryliskiene, K., Licenik, R., Ferdinand, P., Jatužis, D., Kõrv, L., Kõrv, J., Pezzini, A., Sinisalo, J., … Martinez-Majander, N. (2025). Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults: A Case-Control Study. Neurology, 104(6), e213369. https://doi.org/10.1212/WNL.0000000000213369 (https://pubmed.ncbi.nlm.nih.gov/40043226/). 6. Li, W., Zhang, J., Zhang, Y., Shentu, W., Yan, S., Chen, Q., Qiao, S., & Kong, Q. (2025). Clinical research progress on pathogenesis and treatment of Patent Foramen Ovale-associated stroke. Frontiers in neurology, 16, 1512399. https://doi.org/10.3389/fneur.2025.1512399 (https://pubmed.ncbi.nlm.nih.gov/40291846/). 7. Smyth, A., O'Donnell, M., Hankey, G. J., Rangarajan, S., Lopez-Jaramillo, P., Xavier, D., Zhang, H., Canavan, M., Damasceno, A., Langhorne, P., Avezum, A., Pogosova, N., Oguz, A., Yusuf, S., & INTERSTROKE investigators (2022). Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study. European heart journal, 43(3), 202–209. https://doi.org/10.1093/eurheartj/ehab738 (https://pubmed.ncbi.nlm.nih.gov/34850877/). 8. Verhoeven, J. I., Fan, B., Broeders, M. J. M., Driessen, C. M. L., Vaartjes, I. C. H., Klijn, C. J. M., & de Leeuw, F. E. (2023). Association of Stroke at Young Age With New Cancer in the Years After Stroke Among Patients in the Netherlands. JAMA network open, 6(3), e235002. https://doi.org/10.1001/jamanetworkopen.2023.5002 (https://pubmed.ncbi.nlm.nih.gov/36976557/). 9. Wegener S. (2022). Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study. European heart journal, 43(3), 210–212. https://doi.org/10.1093/eurheartj/ehab755 (https://pubmed.ncbi.nlm.nih.gov/34850880/). 10. Yaghi, S., Bernstein, R. A., Passman, R., Okin, P. M., & Furie, K. L. (2017). Cryptogenic Stroke: Research and Practice. Circulation research, 120(3), 527–540. https://doi.org/10.1161/CIRCRESAHA.116.308447 (https://pubmed.ncbi.nlm.nih.gov/28154102/). 11. Yang, D., & Elkind, M. S. V. (2023). Current perspectives on the clinical management of cryptogenic stroke. Expert review of neurotherapeutics, 23(3), 213–226. https://doi.org/10.1080/14737175.2023.2192403 (https://pubmed.ncbi.nlm.nih.gov/36934333/).
Send us a textDave Rosa is President & Chief Executive Officer of NeuroOne ( https://nmtc1.com/ ), a developmental-stage medical technology company developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions ( https://nmtc1.com/technology ). The company's initial focus is on epilepsy and the fast‑growing neurostimulation device market.Mr. Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa's background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.IMPORTANT EPISODE LINKS - Electrochemical Testing of a New Polyimide Thin Film Electrode for Stimulation, Recording, and Monitoring of Brain Activity -https://pmc.ncbi.nlm.nih.gov/articles/PMC9611492/First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity—Part 1: Biocompatibility Testing -https://pmc.ncbi.nlm.nih.gov/articles/PMC9100917/#NeuroOne #DaveRosa #MinimallyInvasive #ThinFilmElectrodes #Theranostics #Stereoelectroencephalography #NeurologicalConditions #Epilepsy #MovementDisorders #ChronicPain #PsychiatricDisorders #Glioblastoma #CognitiveDisorders #Neurostimulation #NerveAblation #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show
In the news show, flu season starts early in the Northern hemisphere due to pesky new strains, so will vaccines be effective? Also, the baby 'swim cap' which promises less invasive brain monitoring, and the European Space Agency's GPS powered satellites which are surveying the water cycle. Then, we find out the best way to shout at seagulls to stop them stealing our snacks... Like this podcast? Please help us by supporting the Naked Scientists
In a special episode of the Neurology Podcast, Dr. Stacey Clardy discusses how AI is shaping various aspects of our lives, including podcasts. Read the related article in Neurology® Open Access. Disclosures can be found at Neurology.org.
Now in its second season, this exclusive CNS Summit podcast series features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients. How is a mid-sized, family-owned company scaling with impact in specialty neurology? Stefan König, CEO of Merz Therapeutics, joins guest host Andy Moniz, VP of Therapeutic Strategy and Innovation at Syneos Health at the 2025 CNS Summit. Together, they explore what it takes to lead through volatility, invest globally and grow with intention, all while upholding culture and delivering with purpose. In this episode: How Merz is leveraging global capital to expand its neurology pipeline What today's market volatility reveals about opportunity Why “balanced disruption” matters for scaling innovation The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.
Dr. Jonathan Howard, neurologist and psychiatrist at NYU Langone and chief of the neurology service at Bellevue Hospital, discusses his dual origin stories. The first as a medical professional and his experiences treating multiple sclerosis and other neuro-immune diseases. The second, understanding the dangers of misinformation in medicine, particularly during the COVID-19 pandemic which he doccuments across two books "We want them infected" and "Everyone Else is Lying to you". Dr. Howard reflects on the lessons learned from COVID-19 and the need for the medical community to regain public trust and effectively combat misinformation.Support the showSupport us and reach out!https://smoothbrainsociety.comhttps://www.patreon.com/SmoothBrainSocietyInstagram: @thesmoothbrainsocietyTikTok: @thesmoothbrainsocietyTwitter/X: @SmoothBrainSocFacebook: @thesmoothbrainsocietyMerch and all other links: Linktreeemail: thesmoothbrainsociety@gmail.com
Dr. Alison Christy talks with Dr. Matthew Ryan Woodward about the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
In part two of this series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss gender disparities in the treatment of multiple sclerosis. Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907
Women and Stroke: Recovery, Prevention and Health Equity In this episode of "Stronger After Stroke," host Rosa Hart, BSN, R.N., SCRN, talks with Tamika Burrus, M.D., a stroke neurology specialist, about how stroke uniquely affects women. Together, they explore critical differences in how women respond to stroke treatments, such as thrombolytics (alteplase and tenecteplase) and mechanical thrombectomy, why recovery can look different for women, and what steps health care systems can take to close the gender gap in stroke outcomes. Dr. Burrus shares insights on physical, cognitive and emotional recovery challenges that women often face after stroke. The conversation also highlights disparities in stroke rehabilitation access, follow-up care and stroke prevention — particularly among Black and Hispanic women, who face a higher risk. Listeners will gain practical takeaways on how women can reduce their stroke risk through lifestyle changes, the importance of early screening by primary care and OB/GYN providers, and how health care professionals can improve outcomes through education, advocacy and equitable care. In this episode, you will learn: How estrogen impacts the cardiovascular system The unique physical, cognitive and emotional recovery challenges women face after stroke Disparities in access to rehabilitation and follow-up care for women compared with men Lifestyle changes that can significantly reduce stroke risk for women at any age How racial and ethnic disparities affect stroke risk among Black and Hispanic women The role of primary care and OB/GYN providers in early stroke risk screening Common misconceptions about stroke in women The most important next steps for women recovering from stroke How nurses and health care professionals can improve stroke outcomes and equity Key takeaway:Women experience stroke differently — biologically, socially and systemically. Improving prevention, early detection and equitable access to care can help save lives and support stronger recoveries. About our guest:Tamika M. Burrus, M.D., is a stroke neurologist with Norton Neuroscience Institute. Dr. Burrus earned her medical degree from the University of Iowa in Iowa City. She completed her residency in neurology at the Mayo Clinic in Rochester, Minnesota, and a fellowship in vascular neurology at the University of California, San Francisco. She is a fellow of the American Academy of Neurology and co-author on several national guidelines for the American Academy of Neurology and the American Heart Association. Dr. Burrus believes it is important to ensure that patients feel as if their interaction is a partnership. She strives to help her patients understand their brain and spine and to collaborate with her regarding the best treatment plan for them. She has specialized expertise in telemedicine and was one of the early adopters in the field of teleneurology. Dr. Burrus is a Louisville native. In her spare time, she enjoys traveling and has visited 44 U.S. states and numerous countries outside North America. Dr. Burrus also likes cooking, art and philanthropic endeavors. Want more inspiring stories and real-life resources? Subscribe and share "Stronger After Stroke" with someone who needs a little extra support navigating life after stroke. For more support after stroke, check out the programs available online and in person through Norton Neuroscience Institute Resource Centers: https://nortonhealthcare.com/services-and-conditions/neurosciences/patient-resources/resource-center/ If you enjoyed this podcast, listen to Norton Healthcare's "MedChat" podcast, available in your favorite podcast app. "MedChat" provides continuing medical education on the go and is targeted toward physicians and clinicians. Norton Healthcare, a not-for-profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. A strong research program provides access to clinical trials in a multitude of areas. More information about Norton Healthcare is available at NortonHealthcare.com. Date of original release: Nov. 10, 2025
On this episode, Dr. James Wyant, Program Director of Sentara and Eastern Virginia Medical School's newly established neurology residency program, joins the podcast to discuss where residents can add value and improve quality of care, improving access to care, and the importance of collaboration across teams and disciplines.
In part one of this two-part series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss what disease-modifying therapies can be safely continued and strategically timed when pregnancy is anticipated. Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi:10.1212/WNL.0000000000213907
On this episode, Dr. James Wyant, Program Director of Sentara and Eastern Virginia Medical School's newly established neurology residency program, joins the podcast to discuss where residents can add value and improve quality of care, improving access to care, and the importance of collaboration across teams and disciplines.
Dr. Stacey Clardy talks with Dr. Sandra Vukusic about the disparities in treatment for female patients with multiple sclerosis, particularly focusing on how pregnancy influences treatment decisions and the overall lower exposure to disease-modifying therapies in women compared to men. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Show citation: McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi:10.1212/WNL.0000000000214086
Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Show citation: McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi:10.1212/WNL.0000000000214086
In this episode of the Brain and Life podcast, co-host Dr. Katy Peters interviews Beth Pinsker, an award-winning journalist and certified financial planner, about her brand new book 'My Mother's Money: A Guide to Financial Caregiving.' They discuss the challenges of handling end-of-life financial decisions, the importance of having key documents like power of attorney, and the emotional and practical aspects of financial caregiving. Dr. Peters is then joined by Dr. Winston Chiong, the Mary Oakley Foundation Professor of Neuroethics in the UCSF Department of Neurology at the Weill Institute for Neuroscience. Dr. Chiong explains what happens in terms of the decision-making capacity of the brain for people with memory concerns, how financial decision making capability is assessed, and how we can support both people with these conditions and caregivers. Additional Resources My Mother's Money: A Guide to Financial Caregiving How to Protect Loved Ones from Financial Scams Cognitive Decline Can Lead to Financial Struggles and Scams—Here's What to Look For Other Brain & Life Podcast Episodes on These Topics Memory and Your Brain, Explained Navigating Complicated Caregiving Journeys with Jacquelyn Revere Journalist, Producer Kitty Eisele's Honest Recount of Her Time as Caregiver We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? · Record a voicemail at 612-928-6206 · Email us at BLpodcast@brainandlife.org Social Media: Guests: Beth Pinsker @bethpinsker_ny; Dr. Winston Chiong @ucsfmedicine Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD
When we think about brain health, most of us jump straight to memory, dementia, or even Alzheimer's. But what if the real starting point is our metabolism?In this episode, I'm joined by Dr Shahrukh Mallik, Consultant Neurologist, to explore how conditions like insulin resistance, type 2 diabetes, and chronic inflammation don't just affect the body, they directly impact the brain.We dive into: ⚡ Why people with type 2 diabetes have up to a 50% higher risk of developing Alzheimer's
Dr. Carole Keim welcomes pediatric neurologist and Assistant Professor in the Department of Neurology at the University of Rochester, Dr. Justin Rosati, MD, to the show to talk about pediatric neurology. They explore what he sees in children as a pediatric neurologist and what parents can look for. Dr. Keim and Dr. Rosati discuss febrile seizures, developmental delays, epilepsy, infantile spasms, and anything neurological that can affect babies and toddlers. Dr. Rosati says that children not meeting a developmental milestone is often why parents bring them in to see him. He works to answer the question of why the child misses or is behind on the milestone and explains what it is that he looks for to see if further testing is needed. He tells Dr. Keim what red flags parents can look out for in terms of neurological conditions. He and Dr. Keim discuss febrile seizures and genetic epilepsy syndromes, as well as when seizure medications might be useful. Dr. Rosati breaks down childhood migraines, how parents can help and identify them, and exactly what neurological disorders entail. It's a wealth of information for parents wanting to know what red flags to keep in mind.Dr. Justin Rosati, MD:Dr. Justin Rosati is an Assistant Professor of Neurology at the University of Rochester. He specializes in Fetal & Neonatal Neurology as well as Clinical Neurophysiology. Dr. Rosati has a special interest in digital media and its use for education for students, residents, parents, and colleagues. He is an active medical content creator focusing on short-form videos for Instagram and TikTok. You can follow him across social media platforms @thebabybraindoc.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__ Contact Dr. Carole Keim, MDlinktree | tiktok | instagram Contact Dr. Justin Rosati, MDlinktree | instagram | University of Rochester Medicine Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
200,000+ leaders have become unbeatable with my elite leadership operating system, will you be the next? Join The Unbeatable Leader Challenge Today: https://www.unbeatableleader.comIn this episode of the Mark Divine Show, host Mark Divine welcomes Rafael McMaster, a visionary creative director and youth mental health advocate. McMaster discusses the shortcomings of the education system in promoting creativity and self-awareness, and shares practical tools for emotional resilience. His non-profit, Indivisible Arts, helps youth cultivate mindfulness and creativity through art. The conversation covers the importance of integrating art into education, the development of a Creative Consciousness community center, and the upcoming online platform to extend these tools nationwide. McMaster's insights emphasize the need for awareness, acceptance, and intention to foster mental well-being in young people.Key Takeaways: -Art as the Language of the Soul and a Tool for PresenceThe absence of art and creative expression in early education leads to a lack of soulful presence and self-connection later in life.-The Mental Health Crisis Among Youth and the Power of Consciousness ToolsTeaching youth to become the "aware observer" of their thoughts (mind watching) and providing them with practical tools like awareness, acceptance, intention, gratitude, compassion, forgiveness, and connection can build emotional resilience and self-regulation.-Community, Co-Creation, and the Ripple EffectBuilding a movement of conscious youth and empowering them to teach each other creates a ripple effect, spreading positive change far beyond the initial group.BUBS Naturals: I use BUBS Naturals daily for focus, recovery, and hydration—all built on a mission to honor a fallen Navy SEAL. Use code UNBEATABLE for 20% off any one time purchase or subscription at www.bubsnaturals.comGuest Links:Website: https://www.indivisiblearts.org/ & https://www.rafaelmcmaster.com/Instagram: https://www.instagram.com/mcmaster.peace/LinkedIn: https://www.linkedin.com/in/rafael-mcmaster-ba573531/YouTube: https://www.youtube.com/channel/UCVP8eNYx58zbFZuBSZj6b8wFacebook: https://www.facebook.com/rafaelmcmasterart/Mark Links: Website: https://unbeatableleader.comYouTube: https://www.youtube.com/@markdivineofficial/Instagram: https://www.instagram.com/markdivineofficialLinkedIn: https://www.linkedin.com/in/markdivine/Facebook: https://www.facebook.com/markdivineofficial/Subscribe to https://www.youtube.com/@markdivineofficial for more inspiring conversations on leadership, growth, and impact.Rate and review the show to help us reach more listeners.Share your thoughts and takeaways in the comments!Timestamps:00:00 Introduction: Defining Art and Its Importance00:41 Welcome to the Mark Divine Show01:23 Introducing Rafael McMaster: Visionary and Advocate02:21 The Power of Art in Everyday Life04:40 The Crisis in Arts Education08:16 Mental Health and Youth: A Growing Concern10:23 Teaching Consciousness and Emotional Resilience16:44 Innovative Approaches to Youth Education26:06 The Heart of Service26:29 Overcoming Homework Hurdles27:45 The Impact of Phones on Youth29:40 A Movement for Conscious Youth30:21 Tools for Overcoming Challenges31:54 The Neurology of Addiction33:56 Mental Health Epidemic43:03 Creative Consciousness Community Centers48:00 Conclusion and Call to Action#leadership #mental toughness #mindset #peakperformance #NavySEAL #executivecoaching #resilience #selfimprovement #growthmindset #unbeatablemind #highperformance #mindfulness #personaldevelopment #warriormindset #stoicleadershipSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr. Jeanine Cook Garard learns that hormonal shifts during menopause don't just affect sleep and mood — they also change how the brain functions. But what can be done to improve memory, stress levels, and mental clarity for midlife women? She speaks with Dr. Therese Huston, a cognitive neuroscientist and the author of Sharp: 14 Simple Ways to Improve Your Life with Brain Science. She is here to help women feel more focused, less overwhelmed, and more like themselves again—using science-backed strategies.
Is it possible to maintain mental acuity well into your golden years? How do we assess ourselves (instead of waiting to see)? Dr. Dale Bredesen earned his M.D. from Duke University Medical Center & served as Chief Resident in Neurology at the University of California. He's now a Neuroscience researcher & internationally recognized expert in the mechanisms of neurodegenerative diseases. His newest book is The Ageless Brain: How to Sharpen and Protect Your Mind for a Lifetime. In this episode, we cover helpful early detection tests, the stages of decline & proven protocols for brain health. If you like this episode, you'll also like episode 285: IS HEART COHERENCE A CHAOS CURE-ALL? HEALTH, BEHAVIOR & INTUITION Guest:https://a.co/d/jawEi3J https://www.apollohealthco.com/ https://www.facebook.com/drdalebredesen/abouthttps://x.com/DrDaleBredesen https://www.instagram.com/apollohealthco/ Host: https://www.meredithforreal.com/ https://www.instagram.com/meredithforreal/ meredith@meredithforreal.comhttps://www.youtube.com/meredithforreal https://www.facebook.com/meredithforrealthecuriousintrovert Sponsors: https://www.jordanharbinger.com/starterpacks/ https://www.historicpensacola.org/about-us/ 00:00 — Why we excuse brain blips01:02 — The doctor redefining “inevitable” Alzheimer's02:15 — Early detection that starts in your kitchen03:40 — Prevention without the sales pitch05:00 — The four stages of cognitive decline07:00 — How to know if you're in stage two08:30 — The MOCA test and what scores really mean11:30 — When neurodivergence clouds self-awareness12:15 — Free tools to gauge your brain health13:00 — Alzheimer's vs. Parkinson's: the subtle difference15:00 — How toxins quietly cripple your mitochondria17:00 — Early signs of Parkinson's most people ignore18:30 — The gut-brain link you need to know20:00 — Mold, metals, and the six “bad guys”22:00 — Functional vs. conventional medicine: finding real help24:00 — Why doctors must ask “why,” not “what”26:00 — The emotional weight of pursuing vitality28:00 — True or false: the biggest Alzheimer's myths30:00 — The genetic odds—and how to beat them31:30 — Oral health and Alzheimer's connection33:00 — The seed oil and statin debate34:30 — Fighting the medical bystander effect38:00 — Ketones, cold plunges, and other brain hacks40:00 — The real deal on nootropics and psychedelics42:30 — When memory and music come back to life44:00 — Screen time, circadian rhythms, and your cognition47:00 — Sugar: the brain's ultimate saboteur49:00 — The KetoFlex 12/3 diet for brainspan52:00 — How sleep detoxes your brain55:00 — Exercise as neuroprotection57:00 — The caregiving paradJoin me and Scott Johnson for a virtual meet up! Thursday, November 6th at 6pm US Central Time.https://us02web.zoom.us/j/89420413041?pwd=n7U64pcT5kNa4bxIEgerlHvj45yblg.1#successRequest to join my private Facebook Group, MFR Curious Insiders https://www.facebook.com/share/g/1BAt3bpwJC/
Dr. Alison Christy talks with Dr. Jennifer L. McGuire about neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Episode description: We continue our campaign to #EndNeurophobia, with the help of Dr. Aaron Berkowitz. This time, Dr. Yousuf Patel presents a case of diplopia and fever to Vale and Sebastian. Yousuf Patel Dr. Yousuf Patel is currently a resident in neurology in Cape Town, South Africa. He completed his undergraduate training at Stellenbosch University. He… Read More »Episode 428: Neurology VMR – Diplopia and fever
The November 2025 Recall revisits four insightful episodes centered on muscle and neuromuscular diseases. Kicking off the episode is a two-part series on myositis, where Dr. Stacey Clardy speaks with Dr. Andrew Mammen. The episode continues with an interview featuring Dr. Eric Voorn, who discusses the effectiveness of combining personalized, home-based aerobic exercise with coaching to improve physical fitness in individuals with neuromuscular diseases. The episode wraps up with Dr. Elia Sechi discussing the critical role of interpreting lab test results, understanding assay performance, and recognizing the real-world impact of false positives in myasthenia gravis diagnostics. Podcast links: Updates on All Things Myositis – Part 1 Updates on All Things Myositis - Part 2 Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice Article links: Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice Show citations: Oorschot S, Brehm MA, van Groenestijn AC, et al. Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical Trial. Neurology. 2025;105(1):e213781. doi:10.1212/WNL.0000000000213781 Zara P, Chessa P, Deiana GA, et al. Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice. Neurology. 2025;104(9):e213498. doi:10.1212/WNL.0000000000213498 Disclosures can be found at Neurology.org.
Dr. Katie Krulisky and Dr. Stefano Meletti discuss the incidence and characteristics of postictal central apnea in focal seizures. Show citation: Meletti S, Burani M, Ballerini A, et al. Persistent Postictal Central Apnea in Focal Seizures: Incidence, Features, and Imaging Findings. Neurology. 2025;105(4):e213856. doi:10.1212/WNL.0000000000213856
Dr. Katie Krulisky talks with Dr. Stefano Meletti about the incidence and characteristics of postictal central apnea in focal seizures. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Greg Cooper and Dr. Claudia Suemoto discuss the association between consumption of low- and no-calorie sweeteners and cognitive decline. Show citations: Gonçalves NG, Martinez-Steele E, Lotufo PA, et al. Association Between Consumption of Low- and No-Calorie Artificial Sweeteners and Cognitive Decline: An 8-Year Prospective Study. Neurology. 2025;105(7):e214023. doi:10.1212/WNL.0000000000214023
Dr. Greg Cooper talks with Dr. Claudia Suemoto about the association between consumption of low- and no-calorie sweeteners and cognitive decline. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
In part one of this two-part series, Dr. Kaitlyn Palmer discusses two new MRI biomarkers to increase diagnostic specificity for multiple sclerosis. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
In this episode, we review the high-yield topic of Complex Partial Seizure from the Neurology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic of Cervical Spine Injury from the Neurology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
In this episode, we review the high-yield topic of Epidural Hematoma from the Neurology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
Dr. Katie Krulisky and Dr. Rosemary Dray-Spira discuss the trends in prenatal exposure to antiseizure medications over the past decade. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213933 Citation: Pouneh S, Jérôme D, Sara M, et al. Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade: A Nationwide Study. Neurology. 2025;105(4): e213933.
Dr. Katie Krulisky talks with Dr. Rosemary Dray-Spira about trends in prenatal exposure to antiseizure medications over the past decade, according to medication safety profiles. Read the related article in Neurology®. Read the related North American Antiepileptic Drug Pregnancy Registry. Read the related Continuum article. Disclosures can be found at Neurology.org.
In this episode, we review the high-yield topic of Friedrich Ataxia from the Neurology section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
© 2020-2025 Ivy Podcast Discovery LLC
